Molly Henderson

Molly Henderson formerly worked at Wuju Foods LLC, as Chairman from 2016 to 2018, Calliditas Therapeutics AB, as Independent Non-Executive Director, Ultralife Corp., as Corporate Controller from 2000 to 2002, PricewaterhouseCoopers LLP, as Manager-Audit Division, Advaxis, Inc., as Chief Financial Officer & Executive Vice President from 2018 to 2020, VirtualScopics, Inc., as CFO, Secretary, Chief Business Officer & SVP in 2013, Phathom Pharmaceuticals, Inc., as CFO, Chief Accounting & Business Officer, UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2020 to 2022, and Iovance Biotherapeutics, Inc., as Chief Financial Officer & Head-Investor Relations from 2015 to 2016.
Ms. Henderson received her graduate degree and Masters Business Admin degree from State University of New York at Buffalo.